General Information

Government Type

State Agency

Entity

Department of Health and Human Services (DHHS)

Public Body

Pharmacy and Therapeutics Committee

Notice Information

Add Notice to Calendar

Notice Title

State Medicaid P&T Committee Meeting

Notice Tags

Medicaid, Pharmacies

Notice Type(s)

Meeting

Event Start Date & Time

November 15, 2018 07:00 AM

Event End Date & Time

November 15, 2018 08:45 AM

Event Deadline Date & Time

11/15/18 08:45 AM

Description/Agenda

AGENDA Utah Department of Health Pharmacy and Therapeutics Committee Thursday, November 15, 2018 7:00 a.m. to 8:45 a.m. Cannon Health Building Room 125 Persons who wish to address the P&T Committee may contact Bryan S. Larson at (bslarson@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - McKay Robinson, PharmD, Chair a) Announce Quorum 2) Welcome and Introductions - McKay Robinson, PharmD, Chair a) Review and Approval of Minutes b) Housekeeping 3) DUR Board Update - Robyn Seely, PharmD 4) Review a) Migraine Prophylaxis - Valerie Martinez, PharmD i) Divalproex, Erenumab-aooe, Galcanezumab-gnlm, Fremanezumab-vfrm, Onabotulinumtoxin A, Propranolol, Timolol, Topiramate b) Public Comment i) Teva - Maria Agapova, MSc, PhD ii) Allergan - Karen Campbell, PharmD iii) Lilly - Anthony Wheeler, PharmD c) Other States Report - Bryan S. Larson, PharmD d) Committee Discussion/Questions e) Committee Action 5) No meetings in December, January, or February. Next Meeting March 21, 2019, Topics: Insulins - Rapid Acting, Insulins - Basal, ACE Inhibitors/ACE Inhibitor Combinations 6) Adjourned - McKay Robinson, PharmD, Chair The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to: Dr. Joanne LaFleur College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Tentative Upcoming Pharmacy & Therapeutics Committee Schedule Month 20 Dec 2018 Topic No meeting Agents No meeting Month 17 Jan 2019 Topic No meeting Agents No meeting Month 21 Feb 2019 Topic No meeting Agents No meeting Month 21 Mar 2019 Topic Insulins - Rapid Acting Insulins - Basal ACE Inhibitors/ACE Inhibitor Combinations Agents Insulin Aspart, Insulin Glulisine, Insulin Lispro, Insulin Regular Insulin Degludec, Insulin Detemir, Insulin Glargine Benazepril, Benazepril/HCTZ, Captopril, Captopril/HCTZ, Enalapril, Enalapril/HCTZ, Fosinopril, Fosinopril/HCTZ, Lisinopril, Lisinopril/HCTZ, Moexipril, Moexipril/HCTZ, Perindopril, Quinapril, Quinapril/HCTZ, Ramipril, Trandolapril Month 20 Jun 2019 Topic ADHD Stimulants Atypical Antipsychotics Sedative Hypnotics Agents Amphetamine, Dexmethylphenidate, Dextroamphetamine, Dextroamphetamine/Amphetamine mixed salts, Lisdexamfetamine, Methamphetamine, Methylphenidate Aripiprazole, Asenapine, Brexpiprazole, Cariprazine, Clozapine, Iloperidone, Lurasidone, Olanzapine, Paliperidone, Quetiapine, Risperidone, Ziprasidone Doxepin, Eszopiclone, Ramelteon, Suvorexant, Tasimelteon, Zaleplon, Zolpidem Month 21 Sep 2019 Topic TBD Agents TBD Please note: all topics are tentative and subject to change.

Notice of Special Accommodations (ADA)

In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Bryan Larson at 801-538-6149.

Notice of Electronic or Telephone Participation

N/A

Meeting Information

Meeting Location

288 North 1460 West
Cannon Health Building - Room 125
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps

Contact Name

Ngan Huynh

Contact Email

nganhuynh@utah.gov

Contact Phone

801-538-6155

Notice Posting Details

Notice Posted On

September 28, 2018 12:54 PM

Notice Last Edited On

October 30, 2018 11:06 AM

Deadline Date

November 15, 2018 08:45 AM

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.